Please check your internet connection and try again.
# MegaClov
## Overview
MegaClov is a combination antibiotic containing Amoxicillin and Clavulanate Potassium. Amoxicillin is a penicillin-class antibiotic, and clavulanate potassium is a beta-lactamase inhibitor.
## Primary Indications
MegaClov is indicated for the treatment of bacterial infections caused by susceptible organisms, including:
* **Lower respiratory tract infections:** Such as acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia.
* **Acute otitis media:** In patients with persistent or severe symptoms.
* **Sinusitis:** Acute bacterial sinusitis.
* **Skin and skin structure infections:** Including cellulitis, animal bites, and abscesses.
* **Urinary tract infections:** Recurrent or complicated urinary tract infections.
## Adult Dosing
* **Standard Dosing:** Typically 500 mg Amoxicillin / 125 mg Clavulanate PO every 8 to 12 hours.
* **Higher Dosing (e.g., for more severe infections or specific indications like sinusitis):** 875 mg Amoxicillin / 125 mg Clavulanate PO every 12 hours.
* **Maximum Daily Dose:** Generally, not to exceed 4000 mg Amoxicillin / 1000 mg Clavulanate daily. Specific maximum doses may vary based on indication and local guidelines.
## Pediatric Dosing
Dosing is based on Amoxicillin component and weight. Clavulanate component is typically dosed at 125 mg for every 250 mg or 500 mg of Amoxicillin.
* **Mild to Moderate Infections:** 25 mg/kg/day to 45 mg/kg/day divided into two doses every 12 hours.
* **Severe Infections:** Up to 90 mg/kg/day divided into two doses every 12 hours.
* **Maximum Pediatric Dose:** Not to exceed the adult maximum dose.
* **Important Note:** For children weighing 40 kg or more, the adult dosage should be used. Oral suspension formulations are often preferred for pediatric use due to ease of administration and dose titration. Specific dosing for certain infections like otitis media may differ.
## Dose Adjustments
* **Renal Impairment:** Dose adjustment is required in adults and pediatric patients with significant renal impairment.
* **CrCl > 30 mL/min:** No dose adjustment needed.
* **CrCl 10-30 mL/min:** Administer usual dose every 12 to 24 hours.
* **CrCl < 10 mL/min:** Administer usual dose every 24 to 48 hours.
* **Hemodialysis:** Administer usual dose every 24 hours and give an additional dose during hemodialysis.
* Pediatric dosing adjustments in renal impairment should follow a similar pattern based on ideal body weight and renal function.
## Contraindications
* Known serious hypersensitivity to Amoxicillin, Clavulanate Potassium, other penicillins, or any component of the formulation.
* History of cholestatic jaundice or hepatic dysfunction associated with Amoxicillin/Clavulanate therapy.
## Adverse Effects
* **Common:** Diarrhea, nausea, vomiting, rash, pruritus, vaginal candidiasis.
* **Serious:**
* **Hypersensitivity Reactions:** Including anaphylaxis and severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis).
* **Hepatotoxicity:** Including cholestatic hepatitis and hepatocellular injury.
* **Clostridioides difficile-associated diarrhea (CDAD):** Ranging in severity from mild diarrhea to fatal colitis.
* **Seizures:** May occur with high doses or in patients with renal impairment.
## Key Drug Interactions
* **Probenecid:** May increase and prolong serum concentrations of amoxicillin.
* **Oral Contraceptives:** May decrease the efficacy of oral contraceptives.
* **Warfarin:** May potentially increase INR; monitoring is advised.
* **Allopurinol:** May increase the incidence of rash.
* **Methotrexate:** Penicillins may decrease the excretion of methotrexate, potentially leading to toxicity.
## Monitoring
* **Renal function:** Especially in patients with pre-existing renal disease or those receiving concurrent nephrotoxic agents.
* **Liver function:** Baseline and periodic monitoring may be considered, particularly with prolonged therapy or in patients with hepatic risk factors.
* **Signs of hypersensitivity reactions:** Monitor closely during and after treatment.
* **Signs of C. difficile infection:** Diarrhea, abdominal cramping, fever.
* **Therapeutic response:** Assess for improvement of infection signs and symptoms.
## Clinical Pearls
* Administer MegaClov at the beginning of a meal to minimize gastrointestinal upset and improve absorption.
* Ensure adequate hydration to prevent crystalluria, especially with high doses.
* Educate patients about the possibility of diarrhea and to report severe or persistent diarrhea to their healthcare provider.
* Clavulanate potassium is susceptible to hydrolysis; reconstitute oral suspensions immediately before dispensing and store refrigerated. Discard unused portions after a specified period (e.g., 10 days).
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your institution's guidelines before making any treatment decisions.
